Component
Blood pantothenate concentration
Blood pantothenate concentration. Experimental scope belongs to the associated record.
3 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What acts on it
Although 49% of female and 15% of male adolescents recorded intakes below 4 mg/day, group-average blood concentrations were within the ranges reported for comparison populations.
Experimental context and source evidence
- availability_state
- biomarker_context Imported condition classification; unverified.
- cross_nutrient
- false
- evidence_location
- Primary indexed abstract.
- experimental_model
- Observational study of 63 healthy adolescents
- exposure
- Four-day diet records; pantothenate measured by radioimmunoassay.
- limitations
- Correlations and comparisons with other populations do not establish cellular adequacy, an individual requirement or a diagnostic threshold. Historical recommended-intake discussion is not used as current guidance. Below 4 mg/day was a historical descriptive cutoff, not a validated individual deficiency threshold.
- nutrient_topic
- Pantothenic acid (vitamin B5) research collection; topical membership is not evidence of a direct dietary effect. · Pantothenate (vitamin B5)
- organism
- Homo sapiens
- plain_language
- A low short diet record did not reliably identify a low group-average blood value.
- primary_references
- [b5-clin-eissenstat1986] Pantothenic acid status of adolescents. (1986). https://pubmed.ncbi.nlm.nih.gov/3788840/ DOI: 10.1093/ajcn/44.6.931
- tissue_or_cell_type
- Diet records, urine, whole blood and erythrocytes
- trigger_kind
- biomarker_context Imported condition classification; unverified.
Pantothenic acid (vitamin B5): coenzyme A, deficiency and nutrient interactions (2026-09-17) · lines 1299–1311
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Observational study of 63 healthy adolescents · source_derived_draft · unverified_draft
### b5-clin-adolescent-intake-blood-discordance Although 49% of female and 15% of male adolescents recorded intakes below 4 mg/day, group-average blood concentrations were within the ranges reported for comparison populations. Condition category: biomarker_context nutrient_topic: Pantothenic acid (vitamin B5) research collection; topical membership is not evidence of a direct dietary effect. plain_language: A low short diet record did not reliably identify a low group-average blood value. organism: Homo sapiens tissue_or_cell_type: Diet records, urine, whole blood and erythrocytes experimental_model: Observational study of 63 healthy adolescents limitations: Correlations and comparisons with other populations do not establish cellular adequacy, an individual requirement or a diagnostic threshold. Historical recommended-intake discussion is not used as current guidance. Below 4 mg/day was a historical descriptive cutoff, not a validated individual deficiency threshold. exposure: Four-day diet records; pantothenate measured by radioimmunoassay. cross_nutrient: false evidence_location: Primary indexed abstract. [b5-clin-eissenstat1986] Pantothenic acid status of adolescents. (1986). https://pubmed.ncbi.nlm.nih.gov/3788840/ DOI: 10.1093/ajcn/44.6.931
Complete structured claim and evidenceWhole-blood pantothenate decreased in the unsupplemented group and remained broadly stable in the supplemented group, but separated intake groups less readily than urinary excretion.
Experimental context and source evidence
- availability_state
- biomarker_context Imported condition classification; unverified.
- cross_nutrient
- false
- evidence_location
- Primary PDF Table 1 visually checked; Tables 3–4 and Results pp.341–345.
- experimental_model
- Controlled 84-day feeding experiment in ten adult male inmates aged 27–33; six unsupplemented and four supplemented
- exposure
- Nine-week/63-day experimental diet essentially free of B5 versus 10 mg/day B5 as calcium pantothenate; both groups then received 100 mg/day for seven days.
- limitations
- Table 1 and the abstract distinguish unsupplemented and supplemented groups; one Methods sentence incorrectly says all received 10 mg. The table was visually checked. Historical assay and small cohort; the reported retention calculation is not direct measurement of intestinal absorption or tissue CoA.
- nutrient_topic
- Pantothenic acid (vitamin B5) research collection; topical membership is not evidence of a direct dietary effect. · Pantothenate (vitamin B5)
- organism
- Homo sapiens
- plain_language
- Blood and urine measurements did not respond identically to dietary depletion.
- primary_references
- [b5-clin-fry1976] Metabolic response to a pantothenic acid deficient diet in humans. (1976). https://pubmed.ncbi.nlm.nih.gov/1011047/ DOI: 10.3177/jnsv.22.339
- tissue_or_cell_type
- Urine and whole blood; nitrogen balance
- trigger_kind
- biomarker_context Imported condition classification; unverified.
Pantothenic acid (vitamin B5): coenzyme A, deficiency and nutrient interactions (2026-09-17) · lines 1243–1255
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Controlled 84-day feeding experiment in ten adult male inmates aged 27–33; six unsupplemented and four supplemented · source_derived_draft · unverified_draft
### b5-clin-blood-intake-response Whole-blood pantothenate decreased in the unsupplemented group and remained broadly stable in the supplemented group, but separated intake groups less readily than urinary excretion. Condition category: biomarker_context nutrient_topic: Pantothenic acid (vitamin B5) research collection; topical membership is not evidence of a direct dietary effect. plain_language: Blood and urine measurements did not respond identically to dietary depletion. organism: Homo sapiens tissue_or_cell_type: Urine and whole blood; nitrogen balance experimental_model: Controlled 84-day feeding experiment in ten adult male inmates aged 27–33; six unsupplemented and four supplemented limitations: Table 1 and the abstract distinguish unsupplemented and supplemented groups; one Methods sentence incorrectly says all received 10 mg. The table was visually checked. Historical assay and small cohort; the reported retention calculation is not direct measurement of intestinal absorption or tissue CoA. exposure: Nine-week/63-day experimental diet essentially free of B5 versus 10 mg/day B5 as calcium pantothenate; both groups then received 100 mg/day for seven days. cross_nutrient: false evidence_location: Primary PDF Table 1 visually checked; Tables 3–4 and Results pp.341–345. [b5-clin-fry1976] Metabolic response to a pantothenic acid deficient diet in humans. (1976). https://pubmed.ncbi.nlm.nih.gov/1011047/ DOI: 10.3177/jnsv.22.339
Complete structured claim and evidencePantothenate after oral pantethine peaked at about 2.5 hours and fitted a two-compartment model with an estimated elimination half-life of 28 hours in the reported cystinosis study.
Experimental context and source evidence
- cross_nutrient
- false
- evidence_location
- Primary indexed abstract.
- experimental_model
- Pharmacokinetic/metabolic study in four children with nephropathic cystinosis
- exposure
- Historical oral D-pantethine exposures 70–1000 mg/kg/day.
- limitations
- Very high drug-like exposures in a rare disease; not nutritional dosing, ordinary healthy-person pharmacokinetics or proof of the mechanism behind lipid-trial effects. Rat intestinal-enzyme kinetic data in the same paper are not assigned to humans. Model-specific estimate at high exposures in four children; not a normal dietary half-life.
- nutrient_topic
- Pantothenic acid (vitamin B5) research collection; topical membership is not evidence of a direct dietary effect. · Pantothenate (vitamin B5)
- organism
- Homo sapiens
- plain_language
- Vitamin exposure persisted after the parent derivative was administered.
- primary_references
- [b5-clin-wittwer1985] Metabolism of pantethine in cystinosis. (1985). https://pubmed.ncbi.nlm.nih.gov/4056044/ DOI: 10.1172/jci112152
- tissue_or_cell_type
- Plasma after oral D-pantethine
Pantothenic acid (vitamin B5): coenzyme A, deficiency and nutrient interactions (2026-09-17) · lines 1481–1493
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Pharmacokinetic/metabolic study in four children with nephropathic cystinosis · source_derived_draft · unverified_draft
### b5-clin-pantethine-pantothenate-kinetics Pantothenate after oral pantethine peaked at about 2.5 hours and fitted a two-compartment model with an estimated elimination half-life of 28 hours in the reported cystinosis study. Condition category: normal nutrient_topic: Pantothenic acid (vitamin B5) research collection; topical membership is not evidence of a direct dietary effect. plain_language: Vitamin exposure persisted after the parent derivative was administered. organism: Homo sapiens tissue_or_cell_type: Plasma after oral D-pantethine experimental_model: Pharmacokinetic/metabolic study in four children with nephropathic cystinosis limitations: Very high drug-like exposures in a rare disease; not nutritional dosing, ordinary healthy-person pharmacokinetics or proof of the mechanism behind lipid-trial effects. Rat intestinal-enzyme kinetic data in the same paper are not assigned to humans. Model-specific estimate at high exposures in four children; not a normal dietary half-life. exposure: Historical oral D-pantethine exposures 70–1000 mg/kg/day. cross_nutrient: false evidence_location: Primary indexed abstract. [b5-clin-wittwer1985] Metabolism of pantethine in cystinosis. (1985). https://pubmed.ncbi.nlm.nih.gov/4056044/ DOI: 10.1172/jci112152
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.